The Central Social Insurance Medical Council in Japan has granted Edwards Lifesciences reimbursement coverage for its Sapien XT system, which is said to be the first transcatheter aortic heart implant to be released in that country. The reimbursement is expected to take effect Oct. 1, and would cover the cost of the device and other hospital fees.
Japan OKs reimbursement coverage for Edwards' heart valve
SmartBrief Job Listings for Health Care
|President/Chief Executive Officer||
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Director, Payer Marketing||
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
|Chief Medical Officer, Texas Children's Health Plan||
Cejka Executive Search for Texas Childre's Health Plan